Dofetilide Therapy is a class III antiarrhythmic pharmacological intervention that selectively inhibits the rapid component of the delayed rectifier potassium current (IKr) to restore and maintain sinus rhythm in patients with atrial fibrillation or atrial flutter.
202
Publications
11.2K
Citations
921
Authors
289
Institutions
Publications per year
2017–2026
22
Parents
Publications
202
Extracellular Potassium Modulation of Drug Block of I<sub>Kr</sub>
Tao Yang, Dan M. Roden · Circulation · 1996 · 433 citations
Medicine, Cardiology, Pharmacology +17
1–5 of 202
Authors
921
- MA
12
h-index
- LK
10
h-index
- JD
8
h-index
- CT
8
h-index
- PO
6
h-index
1–5 of 921
Institutions
289
Pfizer (United Kingdom)
Tadworth, United Kingdom
16 h-index
58 publications
7K citations
University Medical Center Utrecht
Utrecht, The Netherlands
13 h-index
110 publications
2.9K citations
Pfizer (United States)
New York, United States
9 h-index
30 publications
4.5K citations
Montreal Heart Institute
Montreal, Canada
8 h-index
19 publications
1.1K citations
St. Antonius Ziekenhuis
Nieuwegein, The Netherlands
8 h-index
23 publications
1.3K citations
Gentofte Hospital
Copenhagen, Denmark
7 h-index
18 publications
4.4K citations
Rigshospitalet
Copenhagen, Denmark
6 h-index
10 publications
652 citations
University of Copenhagen
Copenhagen, Denmark
6 h-index
30 publications
661 citations
1–8 of 289
Venues
- Circulation
14 publications · 2.4K citations
14
h-index
- Journal of Cardiovascular Pharmacology
15 publications · 587 citations
14
h-index
- Journal of Cardiovascular Electrophysiology
14 publications · 486 citations
12
h-index
- Cardiovascular Research
CVR · 11 publications · 631 citations
11
h-index
- The American Journal of Cardiology
10 publications · 409 citations
10
h-index
1–5